Q & M Dental Group (Singapore) (QC7) H2 2024 earnings summary

Executive summary

• Revenue reached S$180.7 million in FY2024, with core dental business contributing S$173.8 million, up S$0.8 million year-over-year, mainly from Malaysia clinics.

• Net profit after tax attributable to owners rose 27% to S$14.6 million, with EBITDA up 3% to S$38.1 million.

• Dividend payout increased to 1.10 Singapore cents per share, representing a 71% payout ratio.

• Strategic expansion included acquisition of Azure Dental in Singapore and consolidation in Malaysia, reducing underperforming clinics.

• Technology advances included regional regulatory approvals for AI-driven dental solutions and expanded partnerships.

Financial highlights

• Core dental business revenue grew to S$173.8 million from S$173.0 million year-over-year.

• Other business revenue declined 29% to S$6.9 million due to cessation of medical laboratory operations.

• EBITDA increased to S$38.1 million, and profit before tax reached S$14.8 million.

• Cash and cash equivalents stood at S$34.3 million; borrowings reduced to S$73.7 million.

• Earnings per share rose to 1.55 cents; NAV per share was 11.19 cents.

Outlook and guidance

• Plans for further regional expansion, especially in Malaysia and the Johor-Singapore Special Economic Zone.

• Continued commercialisation of AI dental solutions, targeting deployment in over 1,100 clinics regionally.

• Focus on sustainability, productivity, and expanding community outreach through the Free Dental Clinic.